Discoordinate re-expression of cardiac fetal genes in Nω-nitro-L-arginine methyl ester (L-NAME) hypertension

Cardiovascular Research

Volumn 57, Issue 1, 2003, Pages 158-167

  Zhang, Ying ^a   Carreras, Daniel ^a   De Bold, Adolfo J ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Gene expression; Hypertension; Hypertrophy; Natriuretic peptide; Nitric oxide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN BETA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; RENIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART ATRIUM MUSCLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEART VENTRICLE WALL; HEART WEIGHT; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; TRANSCRIPTION INITIATION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HEART VENTRICLES; HYPERTENSION; MALE; MYOCARDIUM; MYOSIN HEAVY CHAINS; NATRIURETIC PEPTIDE, BRAIN; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, SPRAGUE-DAWLEY; RENIN; RNA, MESSENGER;

EID: 0037214567     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00654-5     Document Type: Article

References (36)

1. Verdecchia P., Carini G., Circo A., et al. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol. 38:2001;1829-1835.
2. Hu L., Manning R.D. Jr., Brands M.W. Long-term cardiovascular role of nitric oxide in conscious rats. Hypertension. 23:1994;185-194.
3. Ribeiro M.O., Antunes E., De Nucci G., Lovisolo S.M., Zatz R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension. 20:1992;298-303.
4. Deng L.Y., Thibault G., Schiffrin E.L. Effect of hypertension induced by nitric oxide synthase inhibition on structure and function of resistance arteries in the rat. Clin Exp Hypertens. 15:1993;527-537.
5. Li J.S., Schiffrin E.L. Resistance artery structure and neuroeffector mechanisms in hypertension induced by inhibition of nitric oxide synthase. Am J Hypertens. 7:1994;996-1004.
6. Jover B., Herizi A., Ventre F., Dupont M., Mimran A. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension. 21:1993;944-948.
7. Arnal J.F., Warin L., Michel J.-B. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J Clin Invest. 90:1992;647-652.
8. Arnal J.F., el Amrani A.I., Chatellier G., Menard J., Michel J.-B. Cardiac weight in hypertension induced by nitric oxide synthase blockade. Hypertension. 22:1993;380-387.
9. Delacretaz E., Hayoz D., Osterheld M.C., et al. Long-term nitric oxide synthase inhibition and distensibility of carotid artery in intact rats. Hypertension. 23:1994;967-970.
10. Sarda I.R., de Bold M.L., de Bold A.J. Optimization of atrial natriuretic factor radioimmunoassay. Clin Biochem. 22:1989;11-15.
11. Cushman D.W., Cheung H.S. Concentrations of angiotensin-converting enzyme in tissues of the rat. Biochim Biophys Acta. 250:1971;261-265.
12. Reneland R., Lithell H. Angiotensin-converting enzyme in human skeletal muscle. A simple in vitro assay of activity in needle biopsy specimens. Scand J Clin Lab Invest. 54:1994;105-111.
13. Ogawa T., Linz W., Stevenson M., et al. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation. 93:1996;2059-2067.
14. Moreno H. Jr., Metze K., Bento A.C., et al. Chronic nitric oxide inhibition as a model of hypertensive heart muscle disease. Basic Res Cardiol. 91:1996;248-255.
15. Takemoto M., Egashira K., Usui M., et al. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest. 99:1997;278-287.
16. Pechanova O., Bernatova I., Pelouch V., Simko F. Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril. J Mol Cell Cardiol. 29:1997;3365-3374.
17. Sladek T., Gerova M., Znojil V., Devat L. Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase. Physiol Res. 45:1996;335-338.
18. Yokota N., Bruneau B.G., Fernandez B.E., et al. Dissociation of cardiac hypertrophy, myosin heavy chain isoform expression, and natriuretic peptide production in DOCA-salt rats. Am J Hypertens. 8:1995;301-310.
19. Bianciotti L.G., de Bold A.J. Effect of selective ET(A) receptor blockade on natriuretic peptide gene expression in DOCA-salt hypertension. Am J Physiol Heart Circ Physiol. 279:2000;H93-H101.
20. Yokota N., Bruneau B.G., Kuroski de Bold M.L., de Bold A.J. Atrial natriuretic factor significantly contributes to the mineralocorticoid escape phenomenon. Evidence for a guanylate cyclase-mediated pathway. J Clin Invest. 94:1994;1938-1946.
21. Lee J., Lee S.H., Kang D.G., Kim S.W. Effects of nitric oxide synthesis inhibition on the atrial natriuretic peptide system. Pharmacol Res. 42:2000;275-279.
22. Gardes J., Poux J.M., Gonzalez M.F., Alhenc-Gelas F., Menard J. Decreased renin release and constant kallikrein secretion after injection of L-NAME in isolated perfused rat kidney. Life Sci. 50:1992;987-993.
23. Scholz H., Kurtz A. Involvement of endothelium-derived relaxing factor in the pressure control of renin secretion from isolated perfused kidney. J Clin Invest. 91:1993;1088-1094.
24. Li J.S., Deng L.Y., Grove K., Deschepper C.F., Schiffrin E.L. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression. Hypertension. 28:1996;188-195.
25. Morton J.J., Beattie E.C., Speirs A., Gulliver F. Persistent hypertension following inhibition of nitric oxide formation in the young Wistar rat: role of renin and vascular hypertrophy. J Hypertens. 11:1993;1083-1088.
26. Akuzawa N., Nakamura T., Kurashina T., et al. Antihypertensive agents prevent nephrosclerosis and left ventricular hypertrophy induced in rats by prolonged inhibition of nitric oxide synthesis. Am J Hypertens. 11:1998;697-707.
27. Bernatova I., Pechanova O., Pelouch V., Simko F. Regression of chronic L-NAME-treatment-induced left ventricular hypertrophy: effect of captopril. J Mol Cell Cardiol. 32:2000;177-185.
28. Xu Y., Arnal J.F., Hinglais N., et al. Renal hypertensive angiopathy. Comparison between chronic NO suppression and DOCA-salt intoxication. Am J Hypertens. 8:1995;167-176.
29. Baylis C., Mitruka B., Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest. 90:1992;278-281.
30. Farhy R.D., Carretero O.A., Ho K.L., Scicli A.G. Role of kinins and nitric oxide in the effects of angiotensin converting enzyme inhibitors on neointima formation. Circ Res. 72:1993;1202-1210.
31. Alpert N.R., Mulieri L.A. Increased myothermal economy of isometric force generation in compensated cardiac hypertrophy induced by pulmonary artery constriction in the rabbit. A characterization of heat liberation in normal and hypertrophied right ventricular papillary muscles. Circ Res. 50:1982;491-500.
32. Holubarsch C., Goulette R.P., Litten R.Z., et al. The economy of isometric force development, myosin isoenzyme pattern and myofibrillar ATPase activity in normal and hypothyroid rat myocardium. Circ Res. 56:1985;78-86.
33. Imamura S., Matsuoka R., Hiratsuka E., et al. Adaptational changes of MHC gene expression and isozyme transition in cardiac overloading. Am J Physiol. 260:1991;H73-H79.
34. Nagai R., Pritzl N., Low R.B., et al. Myosin isozyme synthesis and mRNA levels in pressure-overloaded rabbit hearts. Circ Res. 60:1987;692-699.
35. Imamura S., Matsuoka R., Hiratsuka E., et al. Local response to cardiac overload on myosin heavy chain gene expression and isozyme transition. Circ Res. 66:1990;1067-1073.
36. Bartunek J., Weinberg E.O., Tajima M., et al. Chronic N(G)-nitro-L-arginine methyl ester-induced hypertension: novel molecular adaptation to systolic load in absence of hypertrophy. Circulation. 101:2000;423-429.